1. Home
  2. GKOS vs UUUU Comparison

GKOS vs UUUU Comparison

Compare GKOS & UUUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • UUUU
  • Stock Information
  • Founded
  • GKOS 1998
  • UUUU 1987
  • Country
  • GKOS United States
  • UUUU United States
  • Employees
  • GKOS N/A
  • UUUU N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • UUUU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • GKOS Health Care
  • UUUU Industrials
  • Exchange
  • GKOS Nasdaq
  • UUUU Nasdaq
  • Market Cap
  • GKOS 5.4B
  • UUUU 4.7B
  • IPO Year
  • GKOS 2015
  • UUUU N/A
  • Fundamental
  • Price
  • GKOS $91.09
  • UUUU $15.50
  • Analyst Decision
  • GKOS Strong Buy
  • UUUU Strong Buy
  • Analyst Count
  • GKOS 13
  • UUUU 5
  • Target Price
  • GKOS $122.08
  • UUUU $16.00
  • AVG Volume (30 Days)
  • GKOS 1.6M
  • UUUU 31.8M
  • Earning Date
  • GKOS 10-29-2025
  • UUUU 11-03-2025
  • Dividend Yield
  • GKOS N/A
  • UUUU N/A
  • EPS Growth
  • GKOS N/A
  • UUUU N/A
  • EPS
  • GKOS N/A
  • UUUU N/A
  • Revenue
  • GKOS $469,820,000.00
  • UUUU $78,742,000.00
  • Revenue This Year
  • GKOS $30.89
  • UUUU N/A
  • Revenue Next Year
  • GKOS $24.36
  • UUUU $105.42
  • P/E Ratio
  • GKOS N/A
  • UUUU N/A
  • Revenue Growth
  • GKOS 30.38
  • UUUU 103.69
  • 52 Week Low
  • GKOS $73.16
  • UUUU $3.20
  • 52 Week High
  • GKOS $163.71
  • UUUU $27.33
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 60.41
  • UUUU 40.90
  • Support Level
  • GKOS $80.91
  • UUUU $14.08
  • Resistance Level
  • GKOS $102.80
  • UUUU $16.92
  • Average True Range (ATR)
  • GKOS 4.63
  • UUUU 1.96
  • MACD
  • GKOS 1.07
  • UUUU -0.81
  • Stochastic Oscillator
  • GKOS 56.85
  • UUUU 13.93

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About UUUU Energy Fuels Inc (Canada)

Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.

Share on Social Networks: